Source: Pediatric Critical Care Medicine. Unidade: HU
Subjects: SEPSE, RECÉM-NASCIDO, TRANSTORNOS HEMORRÁGICOS, FÁRMACOS (EFEITOS ADVERSOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HSIN, Shieh Huei et al. Comparison of main trials of recombinant human activated protein C in sepsis: are we encouraging more bleeding in neonates? [letter]. Pediatric Critical Care Medicine. Baltimore: Hospital Universitário, Universidade de São Paulo. Disponível em: https://doi.org/10.1097/PCC.0b013e3181e28c12. Acesso em: 01 nov. 2024. , 2010APA
Hsin, S. H., Barreira, E. R., Goes, P. F., Bousso, A., Ventura, G. A. B., Melo, A. M. A. G. P. de, & Ibidi, S. M. (2010). Comparison of main trials of recombinant human activated protein C in sepsis: are we encouraging more bleeding in neonates? [letter]. Pediatric Critical Care Medicine. Baltimore: Hospital Universitário, Universidade de São Paulo. doi:10.1097/PCC.0b013e3181e28c12NLM
Hsin SH, Barreira ER, Goes PF, Bousso A, Ventura GAB, Melo AMAGP de, Ibidi SM. Comparison of main trials of recombinant human activated protein C in sepsis: are we encouraging more bleeding in neonates? [letter] [Internet]. Pediatric Critical Care Medicine. 2010 ; 11( 6): 767-768.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1097/PCC.0b013e3181e28c12Vancouver
Hsin SH, Barreira ER, Goes PF, Bousso A, Ventura GAB, Melo AMAGP de, Ibidi SM. Comparison of main trials of recombinant human activated protein C in sepsis: are we encouraging more bleeding in neonates? [letter] [Internet]. Pediatric Critical Care Medicine. 2010 ; 11( 6): 767-768.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1097/PCC.0b013e3181e28c12
